drugset / Trial / NCT01046422
Safety Study of BMS-770767 in Subjects With Type 2 Diabetes
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine if BMS-770767 is safe, well tolerated, measure its levels in the blood (pharmacokinetics), and measure the levels of chemicals (biomarkers) that may be affected by this drug (pharmacodynamics) in a type 2 diabetes patient population
Timeline
- Start
- 2010-05
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-770767 | Unknown | 15 mg | Oral |
| Subject | BMS-770767 | Unknown | 50 mg | Oral |
| Subject | BMS-770767 | Unknown | 150 mg | Oral |
| Background | Metformin | Small molecule | 1500 mg | Oral |